id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S8484 R27844 |
Yoshihara (Controls exposed to MMI), 2021 | Aproctia | 1st trimester | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.04 [0.00;2.15] C excluded (control group) |
0/541 0/23 | 0 | 541 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8481 R27778 |
Yoshihara (Controls unexposed, sick), 2021 | Aproctia | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 0.29 [0.01;7.19] C | 0/541 1/475 | 1 | 541 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3359 R6106 |
Howley, 2017 | Ano-rectal atresia | 1st trimester | case control | unexposed, disease free | Adjustment: No | 8.62 [1.71;40.10] | 4/14 1,048/12,338 | 1,052 | 14 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3355 R6075 |
Yoshihara (control exposed to MMI), 2012 | Imperforate anus | 1st trimester | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No |
0.88 [0.05;14.08] C excluded (control group) |
1/1,399 1/1,231 | 2 | 1,399 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3354 R6032 |
Yoshihara (control unexposed, sick), 2012 | Imperforate anus | 1st trimester | retrospective cohort | unexposed, sick | Adjustment: No | 0.68 [0.06;7.52] C | 1/1,399 2/1,906 | 3 | 1,399 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 1.62 [0.19;14.09] | 1,056 | 1,954 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, sick; 2: control unexposed, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 3355, 8484